-+ 0.00%
-+ 0.00%
-+ 0.00%

ST Eight Ling announced that the company signed an equity transfer framework agreement with Guangxi Detianhou Investment Co., Ltd., involving 36% of the shares of the target company, Beijing Hongrun Tianyuan Gene Biotechnology Co., Ltd.

Zhitongcaijing·12/30/2025 11:25:04
Listen to the news
ST Eight Ling announced that the company signed an equity transfer framework agreement with Guangxi Detianhou Investment Co., Ltd., involving 36% of the shares of the target company, Beijing Hongrun Tianyuan Gene Biotechnology Co., Ltd.